Oxford BioDynamics (STU:LMQ) OCF Margin %: -532.31% (As of Sep. 2025)

What is Oxford BioDynamics OCF Margin %?

Oxford BioDynamics STU:LMQ OCF Margin % is -532.31% as of Sep. 2025. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Oxford BioDynamics ranks worse than 93.14% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Oxford BioDynamics's Cash Flow from Operations for the six months ended in Sep. 2025 was €-3.11 Mil. Oxford BioDynamics's Revenue for the six months ended in Sep. 2025 was €0.59 Mil. Therefore, Oxford BioDynamics's OCF Margin % for the quarter that ended in Sep. 2025 was -532.31%.

As of today, Oxford BioDynamics's current OCF Yield % is -106.96%.

The historical rank and industry rank for Oxford BioDynamics's OCF Margin % or its related term are showing as below:

STU:LMQ' s OCF Margin % Range Over the Past 10 Years
Min: -3361.69 Med: -718.72 Max: -123.56
Current: -694.02

During the past 13 years, the highest OCF Margin % of Oxford BioDynamics was -123.56%. The lowest was -3361.69%. And the median was -718.72%.

STU:LMQ's OCF Margin % is ranked worse than
93.14% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755 vs STU:LMQ: -694.02

Oxford BioDynamics OCF Margin % Related Terms

Oxford BioDynamics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Oxford BioDynamics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioDynamics OCF Margin % Chart

Oxford BioDynamics Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

OCF Margin %

Get a 7-Day Free Trial

-1,736.18

-3,364.77

-1,627.41

-1,599.34

-691.44

Oxford BioDynamics Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25
OCF Margin %	Get a 7-Day Free Trial															-1,060.12	-1,061.78	-2,170.38	-828.77	-532.31

STU:LMQ vs TMO, DHR, IDXX: OCF Margin % Comparison

For the Diagnostics & Research subindustry, Oxford BioDynamics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics OCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's OCF Margin % falls into.

Save Embed

Oxford BioDynamics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Oxford BioDynamics's OCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Sep. 2025 )	/	Revenue (A: Sep. 2025 )
	=	-8.719	/	1.261
	=	-691.44 %

Oxford BioDynamics's OCF Margin for the quarter that ended in Sep. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Sep. 2025 )	/	Revenue (Q: Sep. 2025 )
	=	-3.114	/	0.585
	=	-532.31 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -532.31% mean?

Oxford BioDynamics (STU:LMQ) has a OCF Margin % of -532.31% as of Sep. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Oxford BioDynamics and its competitors. According to the industry distribution chart, Oxford BioDynamics ranks #190 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 93.1%.

Is Oxford BioDynamics' OCF Margin % too high?

Oxford BioDynamics' current OCF Margin % is -532.31%. Based on the distribution chart, Oxford BioDynamics ranks #190 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.

How does Oxford BioDynamics' OCF Margin % compare to TMO and DHR?

According to the Medical Diagnostics & Research industry distribution chart, Oxford BioDynamics ranks #190 out of 204 companies for OCF Margin %. This places Oxford BioDynamics in the lower half of its industry. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Medical Diagnostics & Research company?

The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Oxford BioDynamics and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford BioDynamics's current OCF Margin % is -532.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Oxford BioDynamics stock overvalued right now?

Based on GuruFocus' analysis, Oxford BioDynamics (STU:LMQ) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.00 — trading 95% below its estimated fair value. The current OCF Margin % is -532.31%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Oxford BioDynamics (STU:LMQ), the current OCF Margin % is -532.31% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxford BioDynamics Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies LSE:GENI LSE:VRCI LSE:PRM LSE:GDR LSE:ABDX TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN MTD DGX LH GH MEDP

Other Exchanges OXBOF:USA OBD:UK

Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB

Website https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.